242 related articles for article (PubMed ID: 18046449)
21. Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101.
Spijkers-Hagelstein JA; Schneider P; Pinhanços SM; Garrido Castro P; Pieters R; Stam RW
Eur J Cancer; 2014 Jun; 50(9):1665-74. PubMed ID: 24703900
[TBL] [Abstract][Full Text] [Related]
22. p38-MAP kinase activation followed by BIM induction is essential for glucocorticoid-induced apoptosis in lymphoblastic leukemia cells.
Lu J; Quearry B; Harada H
FEBS Lett; 2006 Jun; 580(14):3539-44. PubMed ID: 16730715
[TBL] [Abstract][Full Text] [Related]
23. Involvement of miR17 pathway in glucocorticoid-induced cell death in pediatric acute lymphoblastic leukemia.
Harada M; Pokrovskaja-Tamm K; Söderhäll S; Heyman M; Grander D; Corcoran M
Leuk Lymphoma; 2012 Oct; 53(10):2041-50. PubMed ID: 22475310
[TBL] [Abstract][Full Text] [Related]
24. Bim polymorphisms: influence on function and response to treatment in children with acute lymphoblastic leukemia.
Gagné V; Rousseau J; Labuda M; Sharif-Askari B; Brukner I; Laverdière C; Ceppi F; Sallan SE; Silverman LB; Neuberg D; Kutok JL; Sinnett D; Krajinovic M
Clin Cancer Res; 2013 Sep; 19(18):5240-9. PubMed ID: 23908358
[TBL] [Abstract][Full Text] [Related]
25. Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.
Chen DW; Saha V; Liu JZ; Schwartz JM; Krstic-Demonacos M
Oncogene; 2013 Jun; 32(25):3039-48. PubMed ID: 22869147
[TBL] [Abstract][Full Text] [Related]
26. Deregulated cell death and lymphocyte homeostasis cause premature lethality in mice lacking the BH3-only proteins Bim and Bmf.
Labi V; Woess C; Tuzlak S; Erlacher M; Bouillet P; Strasser A; Tzankov A; Villunger A
Blood; 2014 Apr; 123(17):2652-62. PubMed ID: 24632712
[TBL] [Abstract][Full Text] [Related]
27. Glutathione S-transferase M1 inhibits dexamethasone-induced apoptosis in association with the suppression of Bim through dual mechanisms in a lymphoblastic leukemia cell line.
Hosono N; Kishi S; Iho S; Urasaki Y; Yoshida A; Kurooka H; Yokota Y; Ueda T
Cancer Sci; 2010 Mar; 101(3):767-73. PubMed ID: 20067466
[TBL] [Abstract][Full Text] [Related]
28. FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells.
Obexer P; Geiger K; Ambros PF; Meister B; Ausserlechner MJ
Cell Death Differ; 2007 Mar; 14(3):534-47. PubMed ID: 16888645
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition.
Bachmann PS; Piazza RG; Janes ME; Wong NC; Davies C; Mogavero A; Bhadri VA; Szymanska B; Geninson G; Magistroni V; Cazzaniga G; Biondi A; Miranda-Saavedra D; Göttgens B; Saffery R; Craig JM; Marshall GM; Gambacorti-Passerini C; Pimanda JE; Lock RB
Blood; 2010 Oct; 116(16):3013-22. PubMed ID: 20647567
[TBL] [Abstract][Full Text] [Related]
30. Functional analyses of Src-like adaptor (SLA), a glucocorticoid-regulated gene in acute lymphoblastic leukemia.
Mansha M; Carlet M; Ploner C; Gruber G; Wasim M; Wiegers GJ; Rainer J; Geley S; Kofler R
Leuk Res; 2010 Apr; 34(4):529-34. PubMed ID: 19631983
[TBL] [Abstract][Full Text] [Related]
31. The pro-apoptotic protein Bim is a convergence point for cAMP/protein kinase A- and glucocorticoid-promoted apoptosis of lymphoid cells.
Zhang L; Insel PA
J Biol Chem; 2004 May; 279(20):20858-65. PubMed ID: 14996839
[TBL] [Abstract][Full Text] [Related]
32. c-Myc overexpression sensitizes Bim-mediated Bax activation for apoptosis induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through regulating Bcl-2/Bcl-xL expression.
Jiang X; Tsang YH; Yu Q
Int J Biochem Cell Biol; 2007; 39(5):1016-25. PubMed ID: 17331788
[TBL] [Abstract][Full Text] [Related]
33. FTY720 induces apoptosis of chronic myelogenous leukemia cells via dual activation of BIM and BID and overcomes various types of resistance to tyrosine kinase inhibitors.
Kiyota M; Kuroda J; Yamamoto-Sugitani M; Shimura Y; Nakayama R; Nagoshi H; Mizutani S; Chinen Y; Sasaki N; Sakamoto N; Kobayashi T; Matsumoto Y; Horiike S; Taniwaki M
Apoptosis; 2013 Nov; 18(11):1437-1446. PubMed ID: 23851982
[TBL] [Abstract][Full Text] [Related]
34. Yin and yang of glucocorticoid receptors in apoptosis.
Horton T
Blood; 2015 Jan; 125(2):209-11. PubMed ID: 25573965
[TBL] [Abstract][Full Text] [Related]
35. Diversity of the apoptotic response to chemotherapy in childhood leukemia.
Liu T; Raetz E; Moos PJ; Perkins SL; Bruggers CS; Smith F; Carroll WL
Leukemia; 2002 Feb; 16(2):223-32. PubMed ID: 11840289
[TBL] [Abstract][Full Text] [Related]
36. Bim is the key mediator of glucocorticoid-induced apoptosis and of its potentiation by rapamycin in human myeloma cells.
López-Royuela N; Balsas P; Galán-Malo P; Anel A; Marzo I; Naval J
Biochim Biophys Acta; 2010 Feb; 1803(2):311-22. PubMed ID: 19914305
[TBL] [Abstract][Full Text] [Related]
37. AICAR induces Bax/Bak-dependent apoptosis through upregulation of the BH3-only proteins Bim and Noxa in mouse embryonic fibroblasts.
González-Gironès DM; Moncunill-Massaguer C; Iglesias-Serret D; Cosialls AM; Pérez-Perarnau A; Palmeri CM; Rubio-Patiño C; Villunger A; Pons G; Gil J
Apoptosis; 2013 Aug; 18(8):1008-16. PubMed ID: 23605481
[TBL] [Abstract][Full Text] [Related]
38. Essential role for the BH3-only protein Bim but redundant roles for Bax, Bcl-2, and Bcl-w in the control of granulocyte survival.
Villunger A; Scott C; Bouillet P; Strasser A
Blood; 2003 Mar; 101(6):2393-400. PubMed ID: 12433687
[TBL] [Abstract][Full Text] [Related]
39. Glucocorticoid-mediated co-regulation of RCAN1-1, E4BP4 and BIM in human leukemia cells susceptible to apoptosis.
Saenz GJ; Hovanessian R; Gisis AD; Medh RD
Biochem Biophys Res Commun; 2015 Aug; 463(4):1291-6. PubMed ID: 26102033
[TBL] [Abstract][Full Text] [Related]
40. Regulation of the proapoptotic BH3-only protein BIM by glucocorticoids, survival signals and proteasome in chronic lymphocytic leukemia cells.
Iglesias-Serret D; de Frias M; Santidrián AF; Coll-Mulet L; Cosialls AM; Barragán M; Domingo A; Gil J; Pons G
Leukemia; 2007 Feb; 21(2):281-7. PubMed ID: 17151701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
